SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-07-189958
Filing Date
2007-08-28
Accepted
2007-08-27 17:55:42
Documents
4
Period of Report
2007-09-25
Effectiveness Date
2007-08-28

Document Format Files

Seq Description Document Type Size
1 NOTICE & PROXY STATEMENT ddef14a.htm DEF 14A 696382
2 GRAPHIC g21529g12c39.jpg GRAPHIC 9412
3 GRAPHIC g21529g88d11.jpg GRAPHIC 10359
4 GRAPHIC g21529g97z57.jpg GRAPHIC 7065
  Complete submission text file 0001193125-07-189958.txt   735250
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12465 | Film No.: 071081659
SIC: 2834 Pharmaceutical Preparations